FDA Clears EchoNext, the First Multicondition AI Tool to Flag Structural Heart Disease From a Standard ECG
The FDA cleared EchoNext, a deep-learning tool that reads a routine 12-lead ECG to flag six forms of hidden structural heart disease, outperforming cardiologists in a Nature study.